Full Enrollment Reached in Rusfertide Trial for PCV

  Clinical trials can provide immense insight into potential treatment options and patient outcomes. Currently, biopharmaceutical company Protagonist Therapeutics, Inc. ("Protagonist") is working to gain insight into the efficacy of…

Continue Reading Full Enrollment Reached in Rusfertide Trial for PCV